Literature DB >> 7679691

Costimulatory signals are required for optimal proliferation of human natural killer cells.

M J Robertson1, T J Manley, C Donahue, H Levine, J Ritz.   

Abstract

CD56dim NK cells, which comprise approximately 90% of human peripheral blood NK cells, respond to IL-2 with cytokine production, up-regulation of functionally relevant surface molecules, and augmented cytolytic activity. Nevertheless, CD56dim NK cells proliferate poorly in response to IL-2 alone. We found that other NK cell mitogens, including IL-4, IL-7, and IL-12, also induced little proliferation of CD56dim NK cells. Indeed, IL-2 stimulated at least 10-fold more NK cell proliferation than did IL-4, IL-7, or IL-12. In contrast, leukocyte-conditioned medium (LCM) induced two- to threefold greater proliferation of CD56dim NK cells than did optimal concentrations of IL-2. Although the calcium ionophore ionomycin did not stimulate proliferation by itself, it markedly augmented LCM-induced proliferation of CD56dim NK cells. Proliferation in response to either LCM alone or LCM together with ionomycin was almost completely abrogated by anti-IL-2R antibodies. Thus, IL-2 appears to be necessary but not sufficient for optimal proliferation of CD56dim NK cells. LCM-induced proliferation of ionomycin-activated CD56dim NK cells was inhibited 24% by anti-IL-1 heteroantisera and 57% by anti-TNF antisera; a combination of both antisera inhibited proliferation by 73%. Furthermore, although rIL-1 and TNF did not induce proliferation by themselves, both cytokines could augment IL-2-induced proliferation of resting or ionomycin-activated NK cells. Hence IL-1 and TNF do not appear to be primary NK cell mitogens, but rather accessory factors that can enhance IL-2-dependent NK cell proliferation. Stimulation through CD2 or CD16 Ag did not enhance LCM-induced NK cell proliferation. However, stimulation with NK-sensitive K562 cells strongly augmented CD56dim NK cell proliferation to LCM or to IL-2, IL-1, and TNF in combination. NK-resistant Daudi cells did not promote the proliferation of highly purified NK cells. Thus, NK cell proliferation may be enhanced by triggering through putative receptors for natural killing, and ionomycin may mimic such triggering. Although IL-2 by itself can induce NK cell proliferation, most NK cells resemble T and B lymphocytes in that they require multiple signals for optimal proliferation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Natural killer cell engineering for cellular therapy of cancer.

Authors:  D R Shook; D Campana
Journal:  Tissue Antigens       Date:  2011-12

2.  Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.

Authors:  A Porgador; O Mandelboim; N P Restifo; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

3.  CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.

Authors:  F Borrego; M J Robertson; J Ritz; J Peña; R Solana
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

4.  Cellular redox status influences both cytotoxic and NF-kappa B activation in natural killer cells.

Authors:  M Valle Blázquez; I Luque; E Collantes; E Aranda; R Solana; J Peña; E Muñoz
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  Later development of Fas ligand-mediated cytotoxicity as compared with granule-mediated cytotoxicity during the maturation of natural killer cells.

Authors:  T Nakazawa; K Agematsu; A Yabuhara
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

6.  Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells.

Authors:  K T Shaw; A M Ho; A Raghavan; J Kim; J Jain; J Park; S Sharma; A Rao; P G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.

Authors:  Hiroyuki Fujisaki; Harumi Kakuda; Noriko Shimasaki; Chihaya Imai; Jing Ma; Timothy Lockey; Paul Eldridge; Wing H Leung; Dario Campana
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

Review 8.  The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Authors:  Bree Foley; Martin Felices; Frank Cichocki; Sarah Cooley; Michael R Verneris; Jeffrey S Miller
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 9.  Expansion and activation of natural killer cells for cancer immunotherapy.

Authors:  Duck Cho; Dario Campana
Journal:  Korean J Lab Med       Date:  2009-04

Review 10.  Role of human natural killer cells in health and disease.

Authors:  T L Whiteside; R B Herberman
Journal:  Clin Diagn Lab Immunol       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.